IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crestline Management, L.P.

Q1 2025 Holdings

Filed 2025-05-15 | 3 holdings | $63.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$56.6M4,160,73289.5%
Sana Biotechnology Inc(SANA)COM799566104$4.7M2,790,9377.4%
8X8 Inc New(EGHT)COM282914100$2.0M990,5803.1%